Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer

Oncogene

Volumn 23, Issue 52, 2004, Pages 8545-8551

  Bartkova, Jirina ^a   Guldberg, Per ^a   Grønbaek, Kirsten ^a   Koed, Karen ^b   Primdahl, Hanne ^b   Møller, Klaus ^b   Lukas, Jiri ^a   Ørntoft, Torben F ^b   Bartek, Jiri ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chk2 kinase; DNA damage; p53; Truncating mutation; Tumour suppressor; Urinary bladder carcinomas

Indexed keywords

CHECKPOINT KINASE 2; DNA; PROTEIN P53;

APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CELL CYCLE; CELL DEATH; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA DAMAGE; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

CARCINOMA; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN-SERINE-THREONINE KINASES; URINARY BLADDER NEOPLASMS;

EID: 9144251762     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207878     Document Type: Article

References (48)

1. Abraham RT. (2001). Genes Dev., 15, 2177-2196.
2. Ahn JY, Li X, Davis HL and Canman CE. (2002). Biol. Chem., 277, 19389-19395.
3. Ahn JY, Schwarz JK, Piwnica-Worms H and Canman CE. (2000). Cancer Res., 60, 5934-5936.
4. Bartek J, Falck J and Lukas J. (2001). Nat. Rev. Mol. Cell. Biol., 2, 877-886.
5. Bartek J and Lukas J. (2001). Curr Opin. Cell Biol., 13, 738-747.
6. Bartek J and Lukas J. (2003). Cancer Cell, 3, 421-429.
7. Bartkova J, Falck J, Rajpert-De Meyts E, Skakkebaek NE, Lukas J and Bartek J. (2001). Oncogene, 20, 5897-5902.
8. Bell DW, Varley JM, Szydlo TE, Rang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE and Haber DA. (1999). Science, 286, 2528-2531.
9. Chehab NH, Malikzay A, Appel M and Halazonetis TD. (2000). Genes Dev., 14, 278-288.
10. Craig A, Scott M, Burch L, Smith G, Ball K and Hupp T. (2003). EMBO Rep., 4, 787-792.
11. D'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, von Zglinicki T, Saretzki G, Carter NP and Jackson SP. (2003). Nature, 426, 194-198.
12. DiTullio RA, Mochan TA, Venere M, Bartkova J, Sehested M, Bartek J and Halazonetis TD. (2002). Nat. Cell Biol., 4, 998-1002.
13. Dong X, Wang L, Taniguchi K, Wang X, Cunningham JM, McDonnell SK, Qian C, Marks AF, Slager SL, Peterson BJ, Smith DI, Cheville JC, Blute ML, Jacobsen SJ, Schaid DJ, Tindall DJ, Thibodeau SN and Liu W. (2003). Am. J. Hum. Genet., 72, 270-280.
14. Falck J, Lukas C, Protopopova M, Lukas J, Selivanova G and Bartek J. (2001). Oncogene, 20, 5503-5510.
15. Grønbsek K, Worm J, Ralfkier E, Ahrenkiel V, Hokland P and Guldberg P. (2002). Blood, 100, 1430-1437.
16. Guldberg P, Nedergaard T, Nielsen HJ, Olsen AC, Ahrenkiel V and Zeuthen J. (1997). Hum. Mutat., 9, 348-355.
17. Hangaishi A, Ogawa S, Qiao Y, Wang L, Hosoya N, Yuji K, Imai Y, Takeuchi K, Miyawaki S and Hirai H. (2002). Blood, 99, 3075-3077.
18. Haruki N, Saito H, Tatematsu Y, Konishi H, Harano T, Masuda A, Osada H, Fujii Y and Takahshi T. (2000). Cancer Res., 60, 4689-4692.
19. Hirao A, Cheung A, Duncan G, Girard PM, Elia AJ, Wakeham A, Okada H, Sarkissian T, Wong JA, Sakai T, de Stanchina E, Bristow RG, Suda T, Lowe SW, Jeggo PA, Elledge SJ and Mak TW. (2002). Mol Cell Biol., 22, 6521-6532.
20. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ and Mak TW. (2000). Science, 287, 1824-1827.
21. Hoeijmakers JH. (2001). Nature, 411, 366-374.
22. Hofman W-K, Miller CV, Tsukasaki T, Tavor S, Ikezoe T, Hoelzer D, Takeuchi S and Koeffler HP. (2001). Leukemia Res., 25, 333-338.
23. Kastan MB and Lim DS. (2000). Nat. Rev. Mol. Cell. Biol., 1, 179-186.
24. Khanna KK and Jackson SP. (2001). Nat. Genet., 27, 247-254.
25. Lee SB, Kim SH, Bell DW, Wahrer DCR, Schiripo TA, Jorczak MM, Sgroi DC, Garber JE, Li FP, Nichols KE, Varley JM, Godwin AK, Shannon KM, Harlow E and Haber DA. (2001). Cancer Res., 61, 8062-8067.
26. Lukas C, Bartkova J, Latella L, Falck J, Mailand N, Schroeder T, Sehested M, Lukas J and Bartek J. (2001). Cancer Res., 61, 4990-4993.
27. Lukas C, Falck J, Bartkova J, Bartek J and Lukas J. (2003). Nat. Cell Biol., 421, 952-960.
28. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N and Stratton MR. (2002). Nat. Genet., 31, 55-59.
29. Matsuoka S, Nakagawa T, Masuda A, Haruki N, Elledge SJ and Takahashi T. (2001). Cancer Res., 61, 5362-5365.
30. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K and Elledge SJ. (2000). Proc. Natl. Acad. Sci. USA, 97, 10389-10394.
31. Melchionna R, Chen XB, Blasina A and McGowan CH. (2000). Nat. Cell Biol., 2, 762-765.
32. Miller CW, Ikezoe T, Krug U, Hofmann WK, Tavor S, Vegesna V, Tsukasaki K, Takeuchi S and Koeffler HP. (2002). Genes Chromosomes Cancer, 33, 17-21.
33. Reddy A, Yuille M, Sullivan A, Repellin C, Bell A, Tidy JA, Evans DJ, Farrell PJ, Gusterson B, Gasco M and Crook T. (2002). Br. J. Cancer, 86, 756-760.
34. Schutte M, Seal S, Barfoot R, Meijers-Heijboer H, Wasielewski M, Evans DG, Eccles D, Meijers C, Lohman F, Klijn J, van den Ouweland A, Futreal PA, Nathanson KL, Weber BL, Easton DF, Stratton MR and Rahman N. (2003). Am. J. Hum. Genet., 72, 1023-1028.
35. Seppälä EH, Ikonen T, Mononen N, Autio V, Rökman A, Matikainen MA, Tammela TLJ and Schleutker J. (2003). Br. J. Cancer, 89, 1966-1970.
36. Shieh SY, Ahn J, Tamai K, Taya Y and Prives C. (2000). Genes Dev., 14, 289-300.
37. Shiloh Y. (2003). Nat. Rev. Cancer, 3, 155-168.
38. Sodha N, Bullock S, Taylor R, Mitchell G, Guertl-Lackner B, Williams RD, Bevan S, Bishop K, McGuire S, Houlston RS and Eeles RA. (2002a). Br. J. Cancer, 87, 1445-1448.
39. Sodha N, Houlston RS, Williams R, Yuille MA, Mangion J and Eeles RA. (2002b). Hum. Mutat., 19, 173-177.
40. Sullivan A, Yuille M, Repellin C, Reddy A, Reelfs O, Bell A, Dunne B, Gusterson BA, Osin P, Farrell PJ, Yulug I, Evans A, Ozcelik T, Gasco M and Crook T. (2002). Oncogene, 21, 1316-1324.
41. Takai H, Naka K, Okada Y, Watanabe M, Harada N, Saito S, Anderson CW, Appella E, Nakanishi M, Suzuki H, Nagashima K, Sawa H, Ikeda K and Motoyama N (2002). EMBO J., 21, 5195-5205.
42. Takai H, Smogorzewska A and de Lange T. (2003). Curr Biol, 13, 1549-1556.
43. Tavor S, Takeuchi S, Tsukasaki K, Miller CW, Hofmann WK, Ikezoe T, Said JW and Koeffler HP. (2001). Leukemic Lymphoma, 42, 517-520.
44. Tort F, Hernandez S, Bea S, Martinez A, Esteller M, Herman JG, Puig X, Camacho E, Sanchez M, Nayach I, Lopez-Guillermo A, Fernandez PL, Colomer D, Hernandez L and Campo E. (2002). Blood, 100 4602-4608.
45. Vahteristo P, Bartkova J, Eerola H, Syrjäkoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomäk K, Heikkilä P, Holli K, Blomqvist C, Bartek J, Kallioniem OP and Nevanlinna H. (2002). Am. J. Hum. Genet., 71 432-438.
46. Vahteristo P, Tamminen A, Karvinen P, Eerola H, Eklund C, Aaltonen LA, Blomqvist C, Aittomaki K and Nevanlinna H (2001). Cancer Res., 61, 5718-5722.
47. Xu X, Tsvetkov L and Stern D. (2002). Mol. Cell. Biol., 22 4419-4432.
48. Zindy F, Williams RT, Baudino TA, Rehg JE, Skapek SX, Cleveland JL, Roussel MF and Sherr CJ. (2003). Proc. Natl. Acad. Sci. USA, 100, 15930-15935.